Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention [NA]

View source ↗

Summary

A clinical trial sponsored by Western Galilee Hospital-Nahariya is evaluating carbetocin versus misoprostol to prevent postpartum hemorrhage and is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Western Galilee Hospital-Nahariya | Conditions: Postpartum Complication, Postpartum Hemorrhage | NA | Status: NOT_YET_RECRUITING